Related Experiment Video
Updated: Oct 13, 2026

A Hyperandrogenic Mouse Model to Study Polycystic Ovary Syndrome
Published on: October 2, 2018
The androgenicity of progestational agents
1University of Southern California School of Medicine, Los Angeles.
Abstract:
Androgenic potency of the progestational component in oral contraceptives (OCs) is difficult to assess. All the 19-nor testosterone progestogens in OC formulations basically have similar potencies and androgenic activities with the exception of norgestrel (NG). NG is the most potent and androgenic of these agents. It is five to ten times as potent as norethindrone (NET); levonorgestrel (1-NG), one of the two isomers of NG and the one responsible for its potency, is ten to 20 times more potent than NET. In addition, 1-NG is several times more androgenic than NET. However, when evaluating OC androgenic potency the antiandrogenic effect of the progestational agent as well as the effects of the estrogenic component have to be considered. Thus, it is useful to assess parameters that are affected by both OC components, such as changes in lipid levels. It may be concluded that given the potential deleterious metabolic effects produced by androgenic compounds, formulations should be used that have the least impact on these parameters.
Related Concept Videos
Teratogenicity
Hormones of the Adrenal Glands
The adrenal cortex, a powerhouse of hormone synthesis, generates over two dozen corticosteroid hormones. The zona glomerulosa produces mineralocorticoids, exemplified by aldosterone, influencing the electrolyte composition of body fluids. The synthesis of glucocorticoids such as cortisol and corticosterone...
Gonadal and Placental Hormones
In males, testosterone is the primary gonadal androgen. It plays a central role in the maturation of male reproductive organs — the penis and testes. Additionally, testosterone is instrumental in the development of secondary sexual characteristics — a deep voice as well as facial and pubic hair growth — and...
Prodrugs
Prodrugs help overcome...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Intrauterine Drug Delivery Systems

